Long COVID in a prospective cohort of home-isolated patients
Bjørn Blomberg, Kristin Greve-Isdahl Mohn, Karl Albert Brokstad, Fan Zhou, Dagrun Waag Linchausen, Bent-Are Hansen, Sarah Lartey, Therese Bredholt Onyango, Kanika Kuwelker, Marianne Sævik, Hauke Bartsch, Camilla Tøndel, Bård Reiakvam Kittang, Bergen COVID-19 Research Group, Rebecca Jane Cox, Nina Langeland, Anders Madsen, Geir Bredholt, Juha Vahokoski, Elisabeth Berg Fjelltveit, Amit Bansal, Mai Chi Trieu, Sonja Ljostveit, Jan Stefan Olofsson, Nina Ertesvåg, Helene Heitmann Sandnes, Anette Corydon, Hanne Søyland, Marianne Eidsheim, Kjerstin Jakobsen, Nina Guldseth, Synnøve Hauge, Bjørn Blomberg, Kristin Greve-Isdahl Mohn, Karl Albert Brokstad, Fan Zhou, Dagrun Waag Linchausen, Bent-Are Hansen, Sarah Lartey, Therese Bredholt Onyango, Kanika Kuwelker, Marianne Sævik, Hauke Bartsch, Camilla Tøndel, Bård Reiakvam Kittang, Bergen COVID-19 Research Group, Rebecca Jane Cox, Nina Langeland, Anders Madsen, Geir Bredholt, Juha Vahokoski, Elisabeth Berg Fjelltveit, Amit Bansal, Mai Chi Trieu, Sonja Ljostveit, Jan Stefan Olofsson, Nina Ertesvåg, Helene Heitmann Sandnes, Anette Corydon, Hanne Søyland, Marianne Eidsheim, Kjerstin Jakobsen, Nina Guldseth, Synnøve Hauge
Abstract
Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of initial illness, increased convalescent antibody titers and pre-existing chronic lung disease. We found that 52% (32/61) of home-isolated young adults, aged 16-30 years, had symptoms at 6 months, including loss of taste and/or smell (28%, 17/61), fatigue (21%, 13/61), dyspnea (13%, 8/61), impaired concentration (13%, 8/61) and memory problems (11%, 7/61). Our findings that young, home-isolated adults with mild COVID-19 are at risk of long-lasting dyspnea and cognitive symptoms highlight the importance of infection control measures, such as vaccination.
Conflict of interest statement
The authors declare no competing interests.
© 2021. The Author(s).
Figures
References
- Gupta A, et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017–1032. doi: 10.1038/s41591-020-0968-3.
- Meeting the challenge of long COVID. Nat. Med.26, 1803 (2020).
- Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
- Menni C, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat. Med. 2020;26:1037–1040. doi: 10.1038/s41591-020-0916-2.
- von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020;395:e109. doi: 10.1016/S0140-6736(20)31282-4.
- Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.
- Lam MH, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch. Intern. Med. 2009;169:2142–2147. doi: 10.1001/archinternmed.2009.384.
- Kerr WR, Coghlan JD, Payne DJ, Robertson L. The laboratory diagnosis of chronic brucellosis. Lancet. 1966;2:1181–1183. doi: 10.1016/S0140-6736(66)90492-2.
- Ayres JG, Smith EG, Flint N. Protracted fatigue and debility after acute Q fever. Lancet. 1996;347:978–979. doi: 10.1016/S0140-6736(96)91470-1.
- Hanevik K, et al. Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study. Clin. Infect. Dis. 2014;59:1394–1400. doi: 10.1093/cid/ciu629.
- White PD, et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet. 2001;358:1946–1954. doi: 10.1016/S0140-6736(01)06961-6.
- Buchwald DS, Rea TD, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am. J. Med. 2000;109:531–537. doi: 10.1016/S0002-9343(00)00560-X.
- Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J. Clin. Virol. 2007;38:1–6. doi: 10.1016/j.jcv.2006.10.011.
- Geense, W. W. et al. New physical, mental, and cognitive problems 1-year post-ICU: a prospective multicenter study. Am. J. Respir. Crit. Care Med.10.1164/rccm.202009-3381OC (2021).
- Kuwelker, K. et al. Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: a case-ascertained study. Lancet Reg. Health Eur.3, 100014 (2021).
- Robbiani DF, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584:437–442. doi: 10.1038/s41586-020-2456-9.
- Beigel JH, et al. Remdesivir for the treatment of Covid-19—final report. N. Engl. J. Med. 2020;383:1813–1826. doi: 10.1056/NEJMoa2007764.
- Chalder T, et al. Development of a fatigue scale. J. Psychosom. Res. 1993;37:147–153. doi: 10.1016/0022-3999(93)90081-P.
- Wessely S, Powell R. Fatigue syndromes: a comparison of chronic ‘postviral’ fatigue with neuromuscular and affective disorders. J. Neurol. Neurosurg. Psychiatry. 1989;52:940–948. doi: 10.1136/jnnp.52.8.940.
- Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–232. doi: 10.1016/S0140-6736(20)32656-8.
- Bellan M, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw. Open. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142.
- Sykes DL, et al. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113–119. doi: 10.1007/s00408-021-00423-z.
- Venturelli S, et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol. Infect. 2021;149:e32. doi: 10.1017/S0950268821000145.
- Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J. Psychosom. Res. 1998;45:53–65. doi: 10.1016/S0022-3999(97)00291-2.
- Fajnzylber J, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 2020;11:5493. doi: 10.1038/s41467-020-19057-5.
- Amanat F, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 2020;26:1033–1036. doi: 10.1038/s41591-020-0913-5.
- Trieu MC, et al. SARS-CoV-2-specific neutralizing antibody responses in Norwegian health care workers after the first wave of COVID-19 pandemic: a prospective cohort study. J. Infect. Dis. 2021;223:589–599. doi: 10.1093/infdis/jiaa737.
Source: PubMed